1Anderson JJ, Ambrose WW. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovariectomized rat models. J Nutr, 1995,125:799s-783s.
2Anderson JJ, Ambrose WW, Garner SC. Biphasic effects of genistein on bone tissue in the ovariectomized,lactating rat model. Proc Soc Exp Biol Med, 1998,217: 345-350.
3Ishimi Y, Miyaura C, Ohmura M, et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology, 1999,140:1893-1900.
4Ishimi Y, Arai N, Wang X, et al. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Commun,2000,274: 697-701.
5Uesugi T,Toda T, Tsuii K, et al. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzein, genistein, and glycitin. Biol Pharm Bull,2001,24: 368-372.
6Thomas C, Manuel J, Mary S. Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J Clin Endocrinol Metab, 2003,88:4362-4370.
7Ho SC, Chan SG,Yi Q, et al. Soy intake and the mainenance of peak bone mass in Hong-Kong Chinese women. J Bone Miner Res, 2001,16:1363-1369.
8Alexandersen P, Toussaint, Christiansen C, et al. Ipriflavone in the treatment of pestmenopausal osteoperosis: a randomized controlled trial. JAMA, 2001,285:1482-1488.
9Sanne KK, Linda K, Diederick EG, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in pestmenopausal women: a randomized controlled trial. JAMA, 2004,1 (292) :65-74.
10Anderson JJB,Chen XW,Boass A,et al. Soy isoflavones:no effects on bone mineral content and bone mineral density in healthy,menstruating young adult women after one year. J Am Coll Nutr,2002,21: 388-393.
